These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Manohar P; Tamhankar AJ; Lundborg CS; Nachimuthu R Front Microbiol; 2019; 10():574. PubMed ID: 30949158 [TBL] [Abstract][Full Text] [Related]
3. A theoretical model of temperate phages as mediators of gut microbiome dysbiosis. Lin DM; Lin HC F1000Res; 2019; 8():. PubMed ID: 31316751 [TBL] [Abstract][Full Text] [Related]
4. The relationship between the phageome and human health: are bacteriophages beneficial or harmful microbes? Fernández L; Duarte AC; Rodríguez A; García P Benef Microbes; 2021 Apr; 12(2):107-120. PubMed ID: 33789552 [TBL] [Abstract][Full Text] [Related]
5. Naturally-occurring and cultured bacteriophages in human therapy. Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040 [TBL] [Abstract][Full Text] [Related]
6. Bacteriophages targeting protective commensals impair resistance against Salmonella Typhimurium infection in gnotobiotic mice. von Strempel A; Weiss AS; Wittmann J; Salvado Silva M; Ring D; Wortmann E; Clavel T; Debarbieux L; Kleigrewe K; Stecher B PLoS Pathog; 2023 Aug; 19(8):e1011600. PubMed ID: 37603558 [TBL] [Abstract][Full Text] [Related]
7. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713 [No Abstract] [Full Text] [Related]
8. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Zurabov F; Zhilenkov E Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669 [TBL] [Abstract][Full Text] [Related]
9. Computational design of phage cocktails based on phage-bacteria infection networks. Menor-Flores M; Vega-Rodríguez MA; Molina F Comput Biol Med; 2022 Mar; 142():105186. PubMed ID: 34998221 [TBL] [Abstract][Full Text] [Related]
11. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779 [TBL] [Abstract][Full Text] [Related]
12. In vivo assessment of bacteriophages specific to multidrug resistant Escherichia coli on fecal bacterial counts and microbiome in nursery pigs. Imklin N; Sriprasong P; Phuttapatimok S; Kaminsonsakul T; Woonwong Y; Jirawattanapong P; Lekcharoensuk P; Thanantong N; Nasanit R Res Vet Sci; 2022 Dec; 151():138-148. PubMed ID: 35914451 [TBL] [Abstract][Full Text] [Related]
13. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Cieplak T; Soffer N; Sulakvelidze A; Nielsen DS Gut Microbes; 2018; 9(5):391-399. PubMed ID: 29517960 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophage targeting microbiota alleviates non-alcoholic fatty liver disease induced by high alcohol-producing Klebsiella pneumoniae. Gan L; Feng Y; Du B; Fu H; Tian Z; Xue G; Yan C; Cui X; Zhang R; Cui J; Zhao H; Feng J; Xu Z; Fan Z; Fu T; Du S; Liu S; Zhang Q; Yu Z; Sun Y; Yuan J Nat Commun; 2023 Jun; 14(1):3215. PubMed ID: 37270557 [TBL] [Abstract][Full Text] [Related]
15. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment. Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831 [TBL] [Abstract][Full Text] [Related]